DOSE-EFFECT RELATION OF CHOLESTYRAMINE IN CHILDREN AND YOUNG ADULTS WITH FAMILIAL HYPERCHOLESTEROLÆMIA
- 1 January 1977
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 309 (8002) , 59-63
- https://doi.org/10.1016/s0140-6736(77)91078-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Therapeutic failure in familial type II hyperlipoproteinemiaMetabolism, 1976
- Receptor-Mediated Control of Cholesterol MetabolismScience, 1976
- Type III Hyperlipoproteinemia: An Analysis of Two Contemporary DefinitionsAnnals of Internal Medicine, 1975
- Familial Hypercholesterolemia (One Form of Familial Type II Hyperlipoproteinemia) A STUDY OF ITS BIOCHEMICAL, GENETIC, AND CLINICAL PRESENTATION IN CHILDHOODJournal of Clinical Investigation, 1974
- Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIAJournal of Clinical Investigation, 1973
- Use of cholestyramine in treatment of children with familial hypercholesterolaemiaArchives of Disease in Childhood, 1973
- NEONATAL DIAGNOSIS OF FAMILIAL TYPE-II HYPERLIPOPROTEINÆMIAThe Lancet, 1973
- Experiences with the Homozygous Cases of Familial HypercholesterolemiaAnnals of Nutrition and Metabolism, 1973
- Treatment of hypercholesterolemia by interference with bile acid metabolismArchives of internal medicine (1960), 1972
- The inheritance of essential familial hypercholesterolemiaThe American Journal of Medicine, 1964